Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Emerging drugs for major depressive disorder: an update.

Rizvi SJ, Kennedy SH.

Expert Opin Emerg Drugs. 2012 Sep;17(3):285-94. doi: 10.1517/14728214.2012.681301. Epub 2012 Apr 25. No abstract available.

PMID:
22530790
2.

New perspectives on glutamate receptor antagonists as antidepressants.

Chung C.

Arch Pharm Res. 2012 Mar;35(4):573-7. doi: 10.1007/s12272-012-0400-8. Review.

PMID:
22553049
3.

Is the problem of a high placebo response unique to antidepressant trials?

Khan A, Bhat A.

J Clin Psychiatry. 2008 Dec;69(12):1979-80. No abstract available.

PMID:
19203480
4.

Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?

Fornaro M, Aguglia E, Dell'Osso L, Perugi G.

Expert Opin Pharmacother. 2011 Dec;12(18):2817-31. doi: 10.1517/14656566.2011.632366. Review.

PMID:
22098226
5.

Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME.

J Clin Psychiatry. 2009 Mar;70(3):344-53. Epub 2009 Feb 24.

PMID:
19254516
6.

Emerging drugs for major depressive disorder.

Kennedy SH, Rizvi SJ.

Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Review.

PMID:
19637989
7.

Treatment of major depression: selection of initial drug.

Potter WZ, Schmidt ME.

Mod Probl Pharmacopsychiatry. 1997;25:1-16. Review. No abstract available.

PMID:
9344366
8.

Suicidal risk in antidepressant drug trials.

Baldessarini RJ, Pompili M, Tondo L.

Arch Gen Psychiatry. 2006 Mar;63(3):246-8. No abstract available.

PMID:
16520428
9.

The modern pharmacopoeia: a return to depressive realism?

Goldberg JF.

Bipolar Disord. 2008 Dec;10(8):969-72. doi: 10.1111/j.1399-5618.2008.00632.x. No abstract available.

PMID:
19594511
10.

Star-D: lessons learned and future implications.

Rush AJ.

Depress Anxiety. 2011 Jul;28(7):521-4. doi: 10.1002/da.20841. No abstract available.

PMID:
21721070
11.

Drugs for depression and bipolar disorder.

[No authors listed]

Treat Guidel Med Lett. 2010 May;8(93):35-42. Review. No abstract available.

PMID:
20414177
12.

Upping the ante on antidepressants.

Malhi GS.

Bipolar Disord. 2008 Dec;10(8):975-8. doi: 10.1111/j.1399-5618.2008.00645.x. No abstract available.

PMID:
19594513
13.

Understanding placebo response in pediatric depression trials.

Emslie GJ.

Am J Psychiatry. 2009 Jan;166(1):1-3. doi: 10.1176/appi.ajp.2008.08101541. No abstract available.

PMID:
19122009
15.

Desvenlafaxine in the treatment of major depressive disorder.

Pae CU.

Expert Opin Pharmacother. 2011 Dec;12(18):2923-8. doi: 10.1517/14656566.2011.636033. Review.

PMID:
22098230
16.

Mirtazapine: a review of its clinical efficacy and tolerability.

Szegedi A, Schwertfeger N.

Expert Opin Pharmacother. 2005 Apr;6(4):631-41. Review. No abstract available.

PMID:
15934889
17.

Antidepressant treatment practice in the face of STAR*D and STEP-BD.

Cassidy F.

Bipolar Disord. 2008 Dec;10(8):973-4. doi: 10.1111/j.1399-5618.2008.00631.x. No abstract available.

PMID:
19594512
18.

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.

Fishbain DA, Detke MJ, Wernicke J, Chappell AS, Kajdasz DK.

Curr Med Res Opin. 2008 Nov;24(11):3105-15. doi: 10.1185/03007990802429627 . Epub 2008 Oct 2.

PMID:
18828958
19.

Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid.

Schilling C, Blum WF, Heuser I, Paslakis G, Wudy SA, Deuschle M.

J Clin Psychopharmacol. 2011 Jun;31(3):390-2. doi: 10.1097/JCP.0b013e3182189d86. No abstract available.

PMID:
21532371
20.

Depressive breakthrough.

Nierenberg AA, Alpert JE.

Psychiatr Clin North Am. 2000 Dec;23(4):731-42. Review.

PMID:
11147244

Supplemental Content

Support Center